Background/Aims: β-arrestin2 has been shown to have a role in human inflammatory disease. However, the role of β-arrestin2 in cigarette smoke-induced inflammation in the lung remains unknown. The aims of this study were to investigate the effects of β-arrestin2 on cigarette smoke condensate (CSC)-induced expression of inflammatory cytokines in the BEAS-2B human bronchial epithelial cell line in vitro, and the mechanisms involved. Methods: The MTT assay determined cell viability of cultured BEAS-2B cells. Autophagy was assessed by western blot, adenoviral mRFP-GFP-LC3 transfection, and immunofluorescence. The effects of β-arrestin2 shRNA knockdown were studied by western blot and real-time reverse transcription-polymerase chain reaction (RT-PCR). Western blot evaluated the AMPK/mTOR signaling pathway. Levels of inflammatory cytokines, interleukin (IL)-6, IL-8, and MCP-1 were measured in cell culture supernatants by enzyme-linked immunosorbent assay (ELISA). Results: CSC suppressed expression of β-arrestin2 in BEAS-2B cells, activated the AMPK/ mTOR signaling pathway, increased cell autophagy and the expression of IL-6, IL-8, and MCP-1,pretreatment with the β-arrestin2 biased ligands, propranolol, and ICI118551 reversed these changes. Inhibition of autophagy reduced the expression of inflammatory cytokines following CSC. Conclusion: In the human bronchial epithelial cell line, BEAS-2B, β-arrestin2 reduced the expression of CSC-induced inflammatory cytokines by inhibiting autophagy, most likely via the AMPK/mTOR signaling pathway.
Introduction
Chronic obstructive pulmonary disease (COPD) is a common respiratory disease characterized by not entirely reversible airflow limitation and clinical symptoms including a chronic cough, dyspnea, and sputum production. COPD exerts a severe effect upon a patient's quality of life and brings heavy economic burden to the families of patients and society in general. Worldwide, COPD currently ranks as the third most common cause of death and the fifth most common cause of chronic disability [1, 2] . However, the etiology and pathogenesis of COPD are still not completely understood, and at present, are generally considered to be closely related to exposure to cigarette smoke which is the most common risk factor for the occurrence and development of COPD [3, 4] .
The mechanisms responsible for lung inflammation as a result of cigarette smoke are highly complex. Chromatographic analysis and mass spectrometry have shown that cigarette smoke contains more than 47, 000 chemical substances, although the main components are nicotine, carbon monoxide and coal tar [5] . Research has shown that cigarette smoke can directly cause bronchial epithelial cells to release a large number of inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), IL-6, and IL-1β. Inflammatory cytokines released by exposure to cigarette smoke can also induce inflammatory cells such as neutrophils, macrophages and lymphocytes to migrate to the airway epithelium and exacerbate the secretion of inflammatory cytokines, which represents a cascade of amplification of inflammation [6, 7] . Therefore, the control of lung inflammation is of vital importance to the prevention and treatment of COPD.
Arrestin was first discovered by Benovic et al [8] . while purifying β-adrenoceptor kinase from the bovine brain. Thus far, four family members of arrestin have been identified. Arrestin1 and arrestin4 are restricted to the visual system and regulate the conduction of light signals. In contrast, arrestin2 and arrestin3 (also known as β-arrestin1 and β-arrestin2) are widely distributed throughout mammalian tissues [9] . Recent studies have shown that β-arrestin is not only involved in the desensitization, internalization, and circulation of β2-adrenergic receptors, but also serves as a signaling pathway independent of G-protein, which has become known as the β-arrestin bias signaling pathway [9] [10] [11] [12] [13] [14] [15] . Propranolol, as a non-selective beta-blocker, blocks the β-adrenoceptor signaling pathway which is coupled to a G-protein ,but prefers to activate the β-arrestin dependent signaling pathway which is independent of G protein. This mechanism is similar to that seen with the non-selective betablocker/alpha-1 blocker, carvedilol, and the selective β2 adrenergic receptor antagonist, ICI118551 [10, 16] .
Autophagy is a process that involves the phagocytosis of impaired or degenerating proteins and organelles within cells, encapsulates these components into vesicles that fuse with lysosomes that are degraded [17] . Autophagy plays an important role in cell homeostasis [18, 19] , cancer [20] , oxidative stress [21, 22] , and inflammatory diseases [23, 24] . There is published evidence to support that autophagy plays an important role in the lung inflammation in COPD [25, 26] . For example, in a previous study published by our group, we found that the levels of pulmonary autophagy in a COPD mouse model were increased, and that the levels of inflammatory cytokines in bronchoalveolar lavage (BAL) fluid were also increased [27] . In another study, Li and co-workers found that silymarin reduced airway inflammation induced by cigarette smoke by inhibiting autophagy and the ERK/p38 MAPK pathway [28] .
We have also previously shown that 14, 15-epoxyeicosatrienoic acid treatment reduces the CSC-induced inflammatory response in bronchial epithelial cells in vitro by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathway [29] . LC3 is a characteristic microtubule-associated protein light chain; when autophagy is activated, LC3-I is converted to LC3-II, and as a consequence, the LC3-II level would be expected to rise. P62/SQSTM1 (P62) is a multifunctional protein that contains a variety of protein domains and plays an important role in many diseases [30] . During the formation of autophagosomes, P62 acts as a bridge between LC3 and polyubiquitinated proteins, transporting damaged organelles or Cell culture and treatment BEAS-2B human lung epithelial cells were purchased from the American Type Culture Collection (Rockville, MD, USA) and seeded in M199 medium (Gibco) containing 10% fetal bovine serum (HyClone) and cultured in a cell incubator at 37°C with 5% CO 2 and 95% air. The cells were spindle-shaped and grew in an adherent manner. Culture media was changed every 2-3 days. During the logarithmic growth phase, cells were treated with propranolol (10 µM), ICI118551 (1μM), rapamycin (50 nM), and 3-MA (200 µM) for 1 h before intervention with CSC (300 mg/L). The control group and other groups contained a 1:1000 dilution of DMSO.
MTT assay BEAS-2B cells (10 4 ) were transferred from a single cell suspension into each well on a 96-well plate, with each well containing 200 μl of culture medium. Cells were then treated with different concentrations of CSC at different time-points. Then, 20 μl of MTT solution (5 mg/ml) was added into each well and incubated for another 4 h. The liquid from each well was then removed and replaced with 150 μl of DMSO. The plates were then oscillated for 10 min. A wavelength of 570 nm was selected to measure the absorption of different groups on the microplate reader. The results were shown as a percentage of the control. All experiments were performed in triplicate.
Transfection assay and adenoviral tandem fluorescent-tagged LC3 (mRFP-GFP-LC3) analysis
The procedure used to transfect and evaluate adenoviral mRFP-GFP-LC3 has been described previously [29] . Briefly, the day before transfection, good quality BEAS-2B cells were seeded into 24-well plates and cultured overnight. The next day, and at a cell density of between 50-70%, viral infection was performed. The adenoviral mRFP-GFP-LC3 was removed from the -80°C freezer in advance and thawed on ice. Transfection steps were performed in strict accordance with the manufacturer's instructions. BEAS-2B cells were transfected with adenoviral mRFP-GFP-LC3 at a multiplicity of infection (MOI) value of 50. The medium was refreshed 6 h later and the cells were cultured for a further 24 h. Transfected BEAS-2B cells were treated with propranolol (10 μM), ICI118551 (1 μM), rapamycin (50 nM), and 3-MA (200 μM) for 1 h prior to CSC intervention (300 mg/L). Cells were then left to incubate for an additional 24 h. Cells were then fixed with 4% paraformaldehyde and viewed under a laser scanning confocal microscope (Olympus, Tokyo, Japan). The yellow spots which appeared after merge indicated autophagosomes, the red spots indicated autolysosomes.The intensity of autophagic change could be determined by counting the different colored fluorescent dots on confocal microscopy. We use an artificial counting method, and at least 50 cells were counted in each experiment.
Lentiviral β-arrestin2 shRNA vector construction and transfection
Lentiviral vectors were designed to carry shRNAs specific to three target sequences within human β-arrestin2, as follows:
5'-GCTAAATCACTAGAAGAGAAA-3'; 5'-GATACCAACTATGCCACAGAT-3'; 5'-CTTCCGCAAAGACCTGTTCAT-3' and scramble shRNA5'-CCTAAGGTTAAGTCGCCCTCG-3'. Cells were transfected with β-arrestin2 shRNA, or negative control shRNA, in accordance with the manufacturer's instructions. The lentivirus was then used to transfect BEAS-2B cells at 5 MOI. After 48 h, transfection efficiency was confirmed by fluorescence microscopy. The knockdown efficiency of shRNA was then verified by real-time reverse transcription-polymerase chain reaction (RT-PCR) and western blot.
Enzyme-linked immunosorbent assay (ELISA)
Supernatants from different groups of cells were collected and used to determine the concentration of inflammatory cytokines. IL-6, IL-8, and MCP-1 were assayed by a human IL-6, IL-8, and MCP-1 ELISA MAX Deluxe product (Biolegend, San Diego, CA, USA) in accordance with the manufacturer's instructions. Each experiment was performed in triplicate.
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Cellular Physiology and Biochemistry Western blot BEAS-2B cells were harvested from 6-well plates, and total protein was extracted with RIPA buffer (Beyotime, Shanghai, China) containing protease inhibitors and phosphoric acid protease inhibitors. The BCA assay kit (Thermo Fisher Scientific) was then used to determine the concentrations of each protein sample. For each sample, 20 μg of protein was loaded per well and separated by 8% or 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Separated proteins were then transferred to nitrocellulose membranes (Applygen Technology, Beijing, China) at 300 mA for 60 min. The membranes were probed with primary antibodies to β-arrestin2 ( 
Real-time polymerase chain reaction (RT-PCR)
Total RNA was extracted from cell samples using an ultra-pure RNA extraction kit (CWBio. Co. Ltd) (Cat. No. CW0581). Reverse transcription was then performed using the HiFi-MMLV cDNA First Strand Synthesis Kit (CWBio. Co., Ltd) (Cat. No. CW0744), according to the manufacturer's instructions. SYBR Green I real-time RT-PCR was then used to detect β-arrestin2 mRNA transcription levels.
The following primers were obtained from Cyagen Biosciences (Guangzhou, China):
Cycling conditions were as follows: 95°C for 10min, followed by 45 cycles of 95°C for 15 s and 60°C for 60 s. Reactions were performed using a Line Gene 9600 Plus fluorescence quantitative PCR system, and analyzed data using the 2 -△△CT method.
Immunofluorescence BEAS-2B cells were transfected with β-arrestin2 shRNA or scramble shRNA, and treated with or without CSC (300 mg/L) for 24 h. Cell slides were washed three times with PBS and fixed with 4% paraformaldehyde for 15 min and then permeabilized with 0.2% Triton X-100 for 10 min at room temperature. Normal goat serum was added to the slides and left to incubate at room temperature for 30 min to block non-specific antibody binding sites. The primary antibody to P62 (1:100) (Cat. No. ab56416) was then added to each slide and the slides placed in a humid box overnight at 4°C.
The next morning, the slides were washed three times with PBST and incubated with Alexa Fluor 647 goat anti-mouse IgG antibody (1:500) (Abcam, Cambridge, MA, USA) (Cat.No.ab150119) in a humid box at 37°C for 1 h,and then ,cells were stained with the blue DNA fluorescent stain 4',6-diamidino-2-phenylindole (DAPI) for 5 min, sealed with a mounting medium containing anti-fluorescence quencher, and then analyzed under a fluorescence microscope (Olympus, Tokyo, Japan).
Statistical analysis
Data were analyzed using the GraphPad Prism6 (GraphPad Software, Inc., San Diego, CA, USA). Data were generated from at least three independent experiments and expressed as the mean ± standard deviation (SD). Data were analyzed using the t-test and one-way analysis of variance (ANOVA). P-values <0.05 were considered to be statistically significant.
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Results
Toxicity of CSC and its effect on the secretion of inflammatory cytokines in Beas-2B cells
MTT assays confirmed the cytotoxicity of CSC on BEAS-2B cell lines. As shown in Fig. 1A , cell viability was reduced in a dose-dependent and time-dependent manner after exposure to different concentrations of CSC during different time points. Cell viability was approximately 70% when exposed to a level of 300 mg/L CSC for 24 h. Therefore, 300 mg/L of CSC was used for 24 h in subsequent experiments. Dimethylsulfoxide (DMSO) was added at a dilution of 1:1000 to the control group at different time points, and the cell viability of BEAS-2B cells was unaffected. Thus,In future experiments, the concentration of DMSO in all groups used was 1:1000.
An enzyme-linked immunosorbent assay (ELISA) was used to investigate whether CSC exposure affected the expression of inflammatory cytokines in BEAS-2B cells. On exposure to 300 mg/L CSC for 24 h, the secretion of the inflammatory cytokines IL-6 (Fig. 1B) , IL-8 ( Fig. 1C) and MCP-1 (Fig. 1D) in the cell supernatants increased in a time-dependent manner, indicating that CSC exposure increased the production of inflammatory cytokines in BEAS-2B cells.
Effect of CSC on the expression of β-arrestin2 and autophagy in BEAS-2B cells
To investigate whether β-arrestin2 and autophagy were involved in regulating the cigarette smoke-induced inflammatory response, the effects of CSC on the expression of β-arrestin2 and autophagy in lung epithelial cells was investigated using western blot. BEAS-2B cells were cultured in 60 mm diameter dishes and exposed to 300 mg/L of CSC during their logarithmic growth phase. Cells were harvested at defined time intervals, and western blot showed that the expression of β-arrestin2 decreased significantly after intervention with 300 mg/L of CSC for 6 h (Fig. 2B) . Exposure to CSC also increased autophagy level in BEAS-2B cells. The expression of P62 levels was significantly reduced 24 h after CSC intervention (Fig.  2C) . The expression of LC3-II increased significantly after CSC intervention for 24 h (Fig. 2D) . 
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β-arrestin2 inhibited the expression of inflammatory cytokines induced by CSC in BEAS-2B cells
The effects of β-arrestin2 on the CSC-induced expression of inflammatory cytokines were investigated by measuring the concentration of IL-6, IL-8, and MCP-1 in the cell supernatant. As shown in Fig. 3 , the ELISA results showed that CSC increased the levels of IL-6, IL-8, and MCP-1 and that pretreatment with propranolol (10 μM) and ICI118551 (1 μM) significantly reduced the levels of these inflammatory cytokines. Pretreatment of BEAS-2B cells was undertaken with the autophagy inducer, rapamycin (50 nM), and the autophagy inhibitor, 3MA (200 μM), prior to CSC intervention. Data showed that the inhibition of autophagy reduced the levels of all inflammatory cytokines, IL-6, IL-8, and MCP-1.
β-arrestin2 inhibited autophagy induced by CSC in BEAS-2B cells
β-arrestin2 has been previously shown to be involved in the regulation of autophagy in diabetic nephropathy [39] . Next,we sought to determine whether β-arrestin2 regulates CSC-induced autophagy. Fig. 4 shows that CSC significantly reduced the expression level of β-arrestin2 and significantly increased autophagy levels in BEAS-2B cells, 24 h after CSC exposure. Pretreatment with the β-arrestin2-biased ligands, propranolol and ICI118551, significantly increased the expression levels of β-arrestin2 (Fig. 4B) , increased the expression levels of P62 (Fig. 4D) and inhibited the expression levels of LC3-II (Fig. 4E) . Rapamycin also activated autophagy, while 3MA inhibited autophagy. To support these findings on the effect of β-arrestin2 on autophagy, the number of autophagosomes and autolysosomes were evaluated following the transfection of adenoviral mRFP-GFP-LC3 into CSC-induced BEAS-2B cells. Both the number of autophagosomes (yellow dots) and autolysosomes (red dots) after merging, significantly increased with CSC treatment, indicating that CSC enhanced autophagy in BEAS-2B cells. Pretreatment with propranolol or ICI118551 significantly reduced the number of both autophagosomes and autolysosomes (Fig. 5A , 5B). These findings showed that β-arrestin2 reduced autophagy induced by CSC in BEAS-2B cells in vitro. 
Knockdown of β-arrestin2 enhances autophagy and inflammation induced by CSC
To further study the effects of β-arrestin2 on autophagy and inflammation induced by CSC, BEAS-2B cells were transfected with lentiviral β-arrestin2 shRNA. Western blot (Fig. 6A, 6B ) and real-time RT-PCR (Fig. 6C) showed that the expression of β-arrestin2 was successfully knocked down. Downregulation of β-arrestin2 with shRNA increased the expression of inflammatory cytokines (Fig. 6D, 6E, 6F ) and the level of autophagy (Fig.  7) . The expression of P62 was supported by immunofluorescence assays (Fig. 7C) , which showed that the knockdown of β-arrestin2 also reduced the levels of P62 in CSC-induced BEAS-2B cells. These results provide more evidence that β-arrestin2 inhibited autophagy and inflammation induced by CSC in BEAS-2B cells. 
β-arrestin2 blocks CSC-induced autophagy through the AMPK/mTOR signaling pathway
Previous research has shown that the AMPK/mTOR signaling pathway regulates autophagy and that this pathway is also involved in cigarette smoke-induced autophagy [42] . To determine whether β-arrestin2 suppresses CSC-induced autophagy through the AMPK/mTOR pathway, we evaluated the expression of p-AMPK/AMPK and p-mTOR/ mTOR by western blot, which is consistent with the findings from a previous study [43] . Western blot data showed that CSC exposure increased levels of p-AMPK, but reduced levels of p-mTOR, and that pretreatment with propranolol and ICI118551 significantly inhibited the phosphorylation of AMPK and increased the phosphorylation of mTOR (Fig. 4A, 4B ). The expression of the AMPK/mTOR signaling pathway components were detected after knockdown of β-arrestin2. As shown in Fig. 7A and 7B, after knockdown of β-arrestin2, phosphorylation of AMPK was increased and phosphorylation of mTOR was decreased in the CSC exposure group, which suggested that β-arrestin2 blocked CSC-induced autophagy via the AMPK/mTOR signaling pathway. 
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Discussion
To the best of our knowledge, this study is the first to investigate the relationship between CSC, β-arrestin2, autophagy, and the expression of inflammatory cytokines, IL-6, IL-8, and MCP-1 in bronchial epithelial cells in vitro. The findings of this study showed that in the human bronchial epithelial cell line, BEAS-2B, β-arrestin2 reduced the expression of CSC-induced inflammatory cytokines by inhibiting autophagy, possibly via the AMPK/ mTOR signaling pathway. Although this was a preliminary study using a cultured bronchial epithelial cell line, the findings of the study may have implications for further studies on the mechanisms of inflammation in the lung, including in chronic obstructive pulmonary disease (COPD).
β-arrestins are closely related to G-protein-coupled receptors and have mainly been studied in the cardiovascular system. However, the roles of β-arrestins in the respiratory system are not yet fully understood. Recently, β-arrestins have become new targets for drug discovery and development, with the aim to discover β-arrestin-biased ligand drugs to provide the protective effects of β-arrestin on cardiomyocytes and inhibit G-proteinmediated myocardial toxicity. For example, Monasky et al. have shown that the β-arrestin biased ligand, TRV120023, inhibited angiotensin II-induced cardiac hypertrophy [44] . It has also previously been shown that the β2-adrenergic receptor agonist, fenoterol, can downregulate toll-like receptor signaling through the β-arrestin2/AMPK pathway and exert antiinflammatory effects [45] . Zhou et al. showed that β-arrestin2 was involved in the secretion of airway mucus in COPD, and that propranolol or ICI118551 can act on the β-arrestin2/ ERK 1/2, p38, MAPK/MUC5AC pathways by blocking transcription and expression of the MUC5AC gene, to reduce airway mucus hypersecretion induced by cigarette smoke [46] . Lee et al. showed that indacaterol could reduce the expression of MMP-9 by inhibiting NF-κB via the activation of β-arrestin2 [47] . The findings of these previous studies raise the possibility that β-arrestin2 might play a role in the pathogenesis of COPD.
Because COPD is associated with smoking, when planning the present study, it was necessary to investigate whether β-arrestin2 was involved in inflammation and autophagy in the bronchial epithelial cells in response to the effects of cigarette smoke. Therefore, the human bronchial epithelial cell line, BEAS-2B, was chosen and the effects of CSC on autophagy, the expression of β-arrestin2, and the expression of IL-6, IL-8, and MCP-1 were studied. The findings of this study showed that the expression of β-arrestin2 decreased when cells were stimulated by CSC but the levels of autophagy and inflammatory cytokines increased. Treatment with the β-arrestin2 biased ligands, propranolol or ICI118551, led to a reduction in the expression of CSC-induced autophagy levels and inflammatory cytokines.
Autophagy has roles in both normal physiological processes and in pathological processes, and although the role of autophagy in human disease remains poorly understood, a further understanding of autophagy in diseases such as COPD may provide approaches to prevention, diagnosis, or treatment. Previous studies have shown that autophagy represents a 'double-edged sword' that has been associated with both protective and detrimental effects. Autophagy is a process that degrades damaged proteins or organelles, maintaining physiological cell metabolism, but excessive or impaired autophagy can promote an inflammatory response and is associated with apoptosis [25, 48] . A recently published study by Vij et al. showed that cigarette smoke can induce impaired autophagy, thereby aggravating the aging of lungs and exacerbating COPD-emphysema [30] .Two previously published studies have also shown that the inhibition of autophagy provided a level of protection against human bronchial epithelial apoptosis induced by cigarette smoke [49, 50] . Zhou et al. showed that autophagy plays an essential role in cigarette smoke-induced mucus production in airway epithelium, both in vitro and in vivo, and inhibition of autophagy was also shown to markedly reduce cigarette smoke extract-induced bronchial mucus production [51] . Therefore, autophagy appears to have a detrimental role in current models of COPD.
In the present study, the levels of autophagy and the expression of inflammatory cytokines were shown to increase after BEAS-2B cells were stimulated with CSC. Following Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry the addition of rapamycin, which is an activator of autophagy, both the level of autophagy and the expression of inflammatory cytokines increased; when the autophagy inhibitor, 3MA, was added the level of autophagy and the expression of inflammatory cytokines decreased. These results indicated that cigarette smoke activated autophagy and induced the secretion of inflammatory cytokines in BEAS-2B cells and that the inhibition of autophagy inhibited the CSC-induced inflammatory response. In a previously published study by our group, we showed that in CSC-induced BEAS-2B cells, autophagy promoted secretion of the inflammatory cytokines, IL-6, IL-8, and MCP-1, by reducing p62 aggregation, which reduced translocation of Nrf2 into the nucleus, downregulating the expression of heme oxygenase-1 (HO-1), which can reduce the expression of inflammatory cytokines [29] .
To investigate the effect of β-arrestin2 on autophagy, in the present study, the β-arrestin2 agonists, propranolol and ICI118551 were used. Western blot showed that following propranolol and ICI118551 treatment, the expression of β-arrestin2 increased and the level of autophagy decreased. The findings from the ELISA data also showed that the expression levels of inflammatory cytokines were reduced. To further investigate the interaction between β-arrestin2 and autophagy, BEAS-2B cells were transfected with β-arrestin2 shRNA to knock down the expression of β-arrestin2. The level of autophagy and inflammatory factors increased after cigarette smoke exposure compared with cells that were treated with scramble shRNA. These results supported that β-arrestin2 inhibited CSCinduced inflammation in BEAS-2B cells in vitro by inhibiting autophagy.
The present study also included a preliminary investigation of the possible pathway by which β-arrestin2 mediates autophagy. As a highly conserved serine/threonine kinase in eukaryotes, adenosine monophosphate-activated protein kinase (AMPK) plays an important role in cell nutrition, energy loss, and oxidative stress [52, 53] . A previous study showed that exposure to cigarette smoke increased the phosphorylation of AMPK in primary culture of cerebral endothelial cells in the C57BL/6 mouse [43] . Exposure to cigarette smoke has been shown to increase AMPK activation in the lungs in a CSC concentration-dependent and timedependent manner [54] . A recent study also showed that the activation of mTOR suppressed airway inflammation and emphysema induced by cigarette smoke via the inhibition of autophagy and cell death [55] . Furlong et al. showed that in the mouse ovary, cigarette smoke exposure activated autophagy by upregulating the AMPK/mTOR pathway [42] . The present study also demonstrated that cigarette smoke induced AMPK activation and activated autophagy through the AMPK/mTOR pathway. Pre-treatment with propranolol or ICI118551 was also shown to inhibit the AMPK/mTOR signaling pathway, and to inhibit autophagy by restoring the levels of β-arrestin2 in BEAS-2B cells. These changes were reversed with the knockdown of β-arrestin2, indicating that β-arrestin2 suppressed autophagy through the AMPK-mTOR signaling pathway.
This study had several limitations and was a preliminary in vitro study of a single bronchial epithelial cell line and did not involve the use of an in vivo animal model or tissue analysis from patients with COPD. However, the findings of this study may provide the basis for future studies on β-arrestin2 and the AMPK/mTOR signaling pathway in chronic inflammatory lung disease, including COPD.
Conclusion
In conclusion,In the human bronchial epithelial cell line, BEAS-2B, β-arrestin2 reduced the expression of CSC-induced inflammatory cytokines by inhibiting autophagy, most likely via the AMPK/mTOR signaling pathway. The preliminary findings of this in vitro study require support with further studies to determine whether β-arrestin2 might provide a potential therapeutic target for patients with COPD.
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